The phenotype of PGC-/MUC1-/MUC2+ may be a predictive biomarker for diagnosing MA or SRCC or distinguishing from tubular adenocarcinoma accompanied by mucinous secretion or signet ring cell scattered distribution. Here, MUC2 is linked to microtia.